AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model

AMFR consortium, Ruizhi Deng, Eva Medico-Salsench, Anita Nikoncuk, Reshmi Ramakrishnan, Kristina Lanko, Nikolas A Kühn, Herma C van der Linde, Sarah Lor-Zade, Fatimah Albuainain, Yuwei Shi, Soheil Yousefi, Ivan Capo, Evita Medici van den Herik, Marjon van Slegtenhorst, Rick van Minkelen, Geert Geeven, Monique T Mulder, George J G Ruijter, Dieter LütjohannEdwin H Jacobs, Henry Houlden, Alistair T Pagnamenta, Kay Metcalfe, Adam Jackson, Siddharth Banka, Lenika De Simone, Abigail Schwaede, Nancy Kuntz, Timothy Blake Palculict, Safdar Abbas, Muhammad Umair, Mohammed AlMuhaizea, Dilek Colak, Hanan AlQudairy, Maysoon Alsagob, Catarina Pereira, Roberta Trunzo, Vasiliki Karageorgou, Aida M Bertoli-Avella, Peter Bauer, Arjan Bouman, Lies H Hoefsloot, Tjakko J van Ham, Mahmoud Issa, Maha S Zaki, Joseph G Gleeson, Rob Willemsen, Namik Kaya, Stefan T Arold, Reza Maroofian

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology